Pharm - Antibiotics, Antifungals, Antivirals Flashcards
Antimicrobial drugs do not readily enter
CNS, bone, prostate, eye
Narrow spectrum penicillin exemplar
Penicillin V
Penicillin V coverage
non-beta lactamase producing gram+ve cocci, treponema pallidum
Extended spectrum penicillin exemplar
Amoxicillin
Amoxicillin coverage
non-beta lactamase producing gram +ve cocci, gram -ve
Common bacterial infections - OM, strep, second line for UTI
Amoxicillin resistance
- Escherichia d/t upregulation of beta-lactamases
- S pneumoniae - overcome by dose
- Moraxella, haemophilus - overcome by adding beta lactamase inhibitor
Monobactam exemplar
Aztreonam
Aztreonam coverage/ use
- Enhanced against gram -ve bacili, none against gram +ve
- For serious infections w/ resistant bacteria incld. pseudomonas (IV)
Carbapenem exemplar
Meropenem
Meropenem coverage/ use
- Similar to penicillins, larger spectrum of gram +ve and -ve
- resistance is growing
- systemic infections and multidrug resistant (IV)
Cephalosporins coverage
1st gen primarily against gram +ve, later increased gram -ve and decreased gram +ve
First gen cephalosporin exemplar
Cephalexin
Cephalexin use
prior to surgery to eliminate skin flora
Second gen cephalosporin exemplar
Cefuroxime
Third gen cephalosporin exemplar
Ceftriaxone
Ceftriaxone uses
- hospital acquired infections
- can enter CNS - meningitis
- gonorrhea
Fourth gen cephalosporin exemplar
Cefepine
Cefepime uses and drawbacks
- treatment of multi-drug resistant
- associated with higher all cause mortality d/t encephalopathy
Beta lactam adverse effects
- common: N/V, diarrhea, rash, urticaria, superinfections (candida)
- less common: fever, vomiting, erythema, dermatitis, angioedema
- Pseudomembranous colitis d/t c difficile
- allergy/ anaphylaxis/ hypersensitivity
Beta lactam classes
Pencillins, monobactam, carbapenems, cephalosporins
Other cell wall inhibitor classes
UDP-MurNAc inhibitor, Glycopeptide, Beta lactamase inhibitor
Fosfomycin mechanism
- interferes with synthesis of UDP-NAM near the beginning of the peptidoglycan synthesis pathway
- rapidly excreted which creates effectively high urinary levels
Fosfomycin dosing
One large dose as resistance rapidly emerges
Vancomycin mechanism
Binding to end of peptidoglycan and interfering with crosslinking
Vancomycin uses
- serious infections caused by gram +ve drug resistant (IV)
Vancomycin adverse effect
- can cause diffuse flushing and pruritis d/t histamine release (red man syndrome)
Beta lactamase inhibitors exemplar
Clavulanic acid aka clavulanate
Clavulanate mechanism
- inhibits class-A beta lactamases
- No intrinsic antimicrobial activity, but serves as surrogate beta-lactamase substrate when given with another beta lactam antibiotic and protects it from destruction
Common bacterial resistance mechanisms
- production of various classes of beta lactamases
- alteration of structure of penicillin-binding proteins
- changes to porins in outer membrane of gram -ve bacteria
Inhibitors of bacterial protein synthesis classes
- Affect 30s - aminoglycosides, tetracyclines
- Affect 50S - macrolides, other
Aminoglycosides exemplar
Gentamicin
Aminoglycoside mechanism
Bind the 30S subunit and interfere with reading of mRNA code –> insertion of wrong amino acid in peptide chain
irreversible
Gentamicin usage
- active against wide range of grame -ve
- used in combination with penicillin to treat serious infection (bacterial endocarditis)
- IV or topical, measure plasma concentration
- has long post-antibiotic effect
Gentamicin adverse effects
- Nephrotoxicity, ototoxicity (more commonly vestibular)
- irreversible toxicity can occur even after drug is discontinued
- one of the most common causes of drug-indcued renal failure
Tetracyclines mechanism
Competitively blocks tRNA binding to the 30S subunit , preventing the addition of a new amino acid
Reversible (bacteriostatic)
Tetracycline dosing info
- oral
- reduce bioavailability if taken w/ mineral supplements, antacids, bismuth salicylate products, dairy
Tetracycline coverage
- Broad spectrum bacteriostatic
- includes rickettsia, spirochetes, mycoplasma, chlamydia
- many common pathogens have developed resistance
Tetracycline adverse effects
- CI in pregnancy, children <8 d/t it concentrating in growing bones and teeth
- permanent tooth discoloration and hypoplasia of enamel
- nephrotoxicity rare - increased risk close to expiration date, w/ other nephrotoxic drugs
- hepatoxicity, esp in pregnancy
- photosensitivity
Macrolides exemplar
Azithromycin
Macrolides mechanism
- Affect 50S subunit
- inhibit peptidyl transferase which links amino acids in growing peptide chain
- interferes with translocation
Macrolides usage
- covers many of the bacteria that cause respiratory tract infections and CAP
- pts with penicillin allergy
- pneumonia in pregnancy
- pts taking other CYP3A4 drugs
Azithromycin use
- reserved for pts w/ penicillin allergies d/t rising resistance and treatment failure
- pneumoniae in pregnancy
- may be preferred for pts taking other CYP3A4 drugs (little effect on this system)
Azithromycin adverse effects
- Common: stomatitis, heartburn, nausea, anorexia, abdominal pain, diarrhea
- Less affinity for motilin receptor and less GI side effects
- Potential cardiac conduction issuse
“Other” 50S affecting exemplar
Clindamycin
Clindamycin mechanism
Interferes with translocation
Clindamycin usage
- Resistant infections like MRSA
- Skin infections in pencillin allergic pts
Clindamycin adverse effects
- Higher rates of GI superinfections than other antibiotics
Antifolate drugs exemplar
Trimethoprim-Sulfamethoxazole
TMP-SMX mechanism
- Synergistic effect by sequential blockade of folate synthesis
- [SMX] 20: [TMP] 1
TMP-SMX usages
- Bacterial prostatitis, vaginitis
- UTI
TMP-SMX adverse effects
- N/V, diarrhea, rash, renal impairment, thrombocytopenia, anemia, agranulocytosis
- May cause false elevation in creatine, hypoglycemia w/ sulfonylureas
- Hypersensitivity reaction, CI in pts with sulfa allergy
- Megaloblastic anemia if dietary folate is low
Fluoroquinolone exemplar
Ciprofloxacin
Fluoroquinolone mechanism
Inhibit the A subunit of DNA gyrase –> inhibits genetic replication d/t accumulation of double stranded breaks
Ciprofloxacin usage
- Second line for UTI, prostatitis, PID
- Should be reserved for serious UTI, when others are not effective
- Resistance increasing through efflux pumps and change to porins
Ciprofloxacin dosing
Absorption decreased if taken w/ mineral supplements, antacids, bismuth salicylate products
Ciprofloxacin adverse effects
- Tendonitis, tendon rupture (high risk in pts >60, concomitant steroid use, transplant pts)
- May cause permanent peripheral neuropathy, alterations in blood glucose
- Seizures, phototoxicity, prolonged QT interval
- Restlessness/ anxiety/ insomnia/ confusion
“Other” Nucleic acid disruptor exemplar
Nitrofurantoin
Nitrofurantoin mechanism
Reduced by bacterial flavoproteins to reactive intermediates which inactivate or alter bacterial ribosomal proteins and other macromolecules
Nitrofurantoin usages
UTI, not pyelonephritis
D/t very short elimination half life, does not persist long enough to be systemically used
Nitrofurantoin adverse effects
- HA, GI (reduced when used in monohydrate/ macrocrystal formulation)
- Long term may cause hepatic toxicity, rarely pulmonary
Clostridium difficile risk
Highest - fluoroquinolones, cephalosporins, aztreonam, carbapenems
Moderate - macrolides, TMP-SMX, Penicillins
Antifungal classes
Polyene, Azole derivatives, allylamines, echinocandins. other
Polyene exemplar
Nystatin
Nystatin uses
- Often used in suspension (“swish and swallow”), available in various
- prophylactic prevention of oral candidiasis in immunocompromise
- Topical not routinely recommended
Polyene mechanism
Selectively binds to ergosterol in membrane, is incorporated, and forms micropores
Azole derivates mechanism
- Inhibit ergosterol biosynthesis via 14 alpha-demethylase –> disrupted membrane structure and function
Azole derivates exemplar
Fluconazole
Fluconazole usage
- Drug of choice for prophylaxis and treatment of common fungal infections, oral and vulvovaginal candidiasis
- only azole derivative that concentrates in CSF - meningitis
Fluconazole adverse effects
- Less affinity for CYP450s, so fewer drug interactions
- systemic administration can cause skin rash, hepatic injury, hematopoietic toxicity, GI distress
- Birth defects with chronic use in doses >400 mg during first trimester
Allylamine mechanism
- Similarly to azole derivatives
- inhibits squalene epoxidase –> disrupts biosynthesis of ergosterol, results in accumulation of toxic squalene
Allylamine exemplar
Terbinafine
Terbinafine usage
Oral drug of choice for fungal nail infections (preferred d/t higher tolerability, efficacy, lower drug interactions)
Terbinafine adverse effects
- GI upset, HA, rash, sensory loss
- rarely severe hepatotoxicity
Other antifungal exemplar
Flucytosine
Flucytosine mechanism
- Pyrimidine analog accumulated by fungal cells –> acts as false nucleotide
- mammalian cells unable to activate drug
- always given with amphotericin B d/t rapid development of resistance
Flucytosine usage
-Cryptococcus neoformans meningitis in advanced HIV/ AIDS
HIV treatment classes
NRTI, NNRTI, Protease inhibitor, fusion/ entry inhibitor, integrase strand transfer inhibitor
Attachment/ entry inhibitor exemplar
Maraviroc
Maraviroc mechanism
Targets host chemokine receptor CCR5
Maraviroc usages
- treatment of HIV when other drugs are ineffective or resistance is high to other drugs
- only effective if pt is infected with HIV that only uses CCR5
- metabolized by CYP3A4 so combination therapy used
NRTI exemplar
Emtricitabine/ Tenofovir
Emtricitabine/ Tenofovir usages
- Treatment of established HIB, pre-exposure prophylaxis
- One of the preferred combinations during pregnancy
- Common backbone to all three common HIV treatment regimes
NRTI mechanism
- Converted to nucleotides by host cell
- Compete with endogenous nucleotides for incorporation into viral DNA, causing chain termination
Emtricitabine/ Tenofovir adverse effects
- Renal, liver toxicity
- Lactic acidosis
- Decreased bone density and risk of fracture
- Lipodystrophy
- HA, nausea, diarrhea, fatigue, depression, insomnia
NNRTI mechanism
- Do not require metabolic activation and directly inhibit reverse transcription
- act synergistically with NRTs and are never used alone
NNRTI exemplar
Efavirenz
Efavirenz usages
- Addition to NRTIs is 1 common regime
- NNRTI of choice when viral load is <100,000
Efavirenz adverse effects
- CNS toxicity - sleep disturbances, abnormal dreams, depression
- Avoid in pts with history of anxiety, depression, psychosis
- Rash
- CI in 1st trimester of pregnancy
- many serious interactions with NNRTIs
HIV Protease inhibitors mechanism
- Inhibits protease activity –> production of immature, non-infectious viral particles
- Synergistic with NRTIs
HIV Protease inhibitor exemplar
Atazanavir
Atazanavir usage
- Combination with NRTIs one of the common regimes
- Given alongside other drugs (boosted therapy) Ritonavir or Cobicistat
Protease inhibitor adverse effects
-Lipodystrophy, hyperlipidemia, insulin resistance and diabetes, liver damage, prolongation of PR interval
HIV integrase inhibitor mechanism
Inhibits integrase, which incorporates viral DNA into DNA of CD4+ cells
HIV integrase inhibitor exemplar
Raltegravir
Raltegravir usage
- Combination with NRTIs one of common regimes
Raltegravir adverse effects
- Cause far fewer as a class
- HA, diarrhea, nausea
- less commonly, neuropsych
- Rarely life threatening skin and hypersensitivity reactions
Herpes DNA polymerase inhibitor mechanism
- Similar to NRTIs
- viral and host kinases must activate
Herpes DNA polymerase inhibitor exemplar
Acyclovir
Acyclovir usage
- Treatment of HSV 1 or 2
- Must be started w/ in 1 hr for orolabial and 7 days for genital
- IV for serious infection
- Suppressive for people who experience 4+ recurrences per year
Acyclovir adverse effects
- Not many - GI, HA, rash most common
Influenza neuraminidase inhibitor exemplar
Oseltamivir
Neuraminidase inhibitor mechanism
- Neuraminidase cannot cleave sialic acid from membrane glycoproteins –> virus remains tethered
Oseltamivir useage
- Chemoprophylaxis and treatment of flu A and B during outbreaks
- dosing dependent on renal function
- Treatment best initiated w/in 48 hours of sx onset
- reduces complications influenza
Oseltamivir adverse effects
N/V, HA